Lipoprotein(a): Emerging insights and therapeutics
The strong association between lipoprotein (a) [Lp(a)] and atherosclerotic cardiovascular disease has led to considerations of Lp(a) being a potential target for mitigating residual cardiovascular risk. While approximately 20 % of the population has an Lp(a) level greater than 50 mg/dL, there are no...
| 出版年: | American Journal of Preventive Cardiology |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Elsevier
2024-06-01
|
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2666667724000096 |